These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31096056)

  • 1. Bone penetration of daptomycin in diabetic patients with bacterial foot infections.
    Grillon A; Argemi X; Gaudias J; Ronde-Ousteau C; Boeri C; Jenny JY; Hansmann Y; Lefebvre N; Jehl F
    Int J Infect Dis; 2019 Aug; 85():127-131. PubMed ID: 31096056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model.
    Dandekar PK; Tessier PR; Williams P; Nightingale CH; Nicolau DP
    J Antimicrob Chemother; 2003 Sep; 52(3):405-11. PubMed ID: 12917254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of daptomycin against strains isolated from diabetic foot ulcers].
    Sotto A; Laouini D; Bouziges N; Jourdan N; Richard JL; Lavigne JP
    Pathol Biol (Paris); 2010 Feb; 58(1):73-7. PubMed ID: 19875242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo pharmacodynamic activity of daptomycin.
    Safdar N; Andes D; Craig WA
    Antimicrob Agents Chemother; 2004 Jan; 48(1):63-8. PubMed ID: 14693519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daptomycin treatment in Gram-positive vascular graft infections.
    Arnaiz de Las Revillas F; Fernandez-Sampedro M; Arnaiz-García AM; Gutierrez-Cuadra M; Armiñanzas C; Pulitani I; Ponton A; Tascon V; García I; Fariñas MC
    Int J Infect Dis; 2018 Mar; 68():69-73. PubMed ID: 29373845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic Analysis of Daptomycin-treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint.
    Avery LM; Kuti JL; Weisser M; Egli A; Rybak MJ; Zasowski EJ; Arias CA; Contreras GA; Chong PP; Aitken SL; DiPippo AJ; Wang JT; Britt NS; Nicolau DP
    Clin Infect Dis; 2019 May; 68(10):1650-1657. PubMed ID: 30188976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics of Daptomycin against Enterococcus faecium and Enterococcus faecalis in the Murine Thigh Infection Model.
    Kidd JM; Abdelraouf K; Asempa TE; Humphries RM; Nicolau DP
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid.
    Johnson AP; Mushtaq S; Warner M; Livermore DM
    Int J Antimicrob Agents; 2004 Oct; 24(4):315-9. PubMed ID: 15380254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS; Watters AA; Fritsche TR; Jones RN
    BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci.
    Cervera C; Castañeda X; Pericas JM; Del Río A; de la Maria CG; Mestres C; Falces C; Marco F; Moreno A; Miró JM
    Int J Antimicrob Agents; 2011 Nov; 38(5):365-70. PubMed ID: 21420835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with daptomycin: bacteraemia and endocarditis.
    Levine DP
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii35-39. PubMed ID: 18829724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daptomycin for methicillin-resistant Staphylococcus aureus diabetic foot infections.
    Joseph WS; Quast T; Cogo A; Crompton MG; Yoon MJ; Lamp KC; Culshaw D; Chaves RL
    J Am Podiatr Med Assoc; 2014 Mar; 104(2):159-68. PubMed ID: 24725036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daptomycin activity tested against 164457 bacterial isolates from hospitalised patients: summary of 8 years of a Worldwide Surveillance Programme (2005-2012).
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    Int J Antimicrob Agents; 2014 May; 43(5):465-9. PubMed ID: 24636430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections.
    Wagenlehner FM; Lehn N; Witte W; Naber KG
    Chemotherapy; 2005 May; 51(2-3):64-9. PubMed ID: 15870498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
    King EA; McCoy D; Desai S; Nyirenda T; Bicking K
    J Antimicrob Chemother; 2011 Sep; 66(9):2112-8. PubMed ID: 21697178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
    Barber KE; Smith JR; Raut A; Rybak MJ
    J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections.
    Traunmüller F; Schintler MV; Metzler J; Spendel S; Mauric O; Popovic M; Konz KH; Scharnagl E; Joukhadar C
    J Antimicrob Chemother; 2010 Jun; 65(6):1252-7. PubMed ID: 20375031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of daptomycin in patients affected by severe Gram-positive infections.
    Di Paolo A; Tascini C; Polillo M; Gemignani G; Nielsen EI; Bocci G; Karlsson MO; Menichetti F; Danesi R
    Int J Antimicrob Agents; 2013 Sep; 42(3):250-5. PubMed ID: 23891432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agar.
    Johnson AP; Mushtaq S; Warner M; Livermore DM
    J Antimicrob Chemother; 2004 May; 53(5):860-2. PubMed ID: 15056637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.